TISSUE TRANSPLANT TECHNOLOGY, LTD. – Trademark Portfolio
Entity Type: 13
TISSUE TRANSPLANT TECHNOLOGY, LTD. holds 21 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 20 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 13 trademarks are registered. Notable registered marks include BONE BANK, STERIFLEX, STERIFUSE, STERISORB, and AMNIOARMOR. The owner is based in SAN ANTONIO, TX.
4808 RESEARCH DRIVE
SAN ANTONIO, TX 78240
Showing of trademarks Trademarks
Trademark Classifications
TISSUE TRANSPLANT TECHNOLOGY, LTD.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does TISSUE TRANSPLANT TECHNOLOGY, LTD. have?
TISSUE TRANSPLANT TECHNOLOGY, LTD. has 21 U.S. trademarks filed with the USPTO. Of these, 13 registered, 5 abandoned, 3 cancelled.
What trademark classes does TISSUE TRANSPLANT TECHNOLOGY, LTD. file in?
TISSUE TRANSPLANT TECHNOLOGY, LTD. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are TISSUE TRANSPLANT TECHNOLOGY, LTD.'s most well-known trademarks?
TISSUE TRANSPLANT TECHNOLOGY, LTD.'s registered trademark portfolio includes well-known marks such as BONE BANK, STERIFLEX, STERIFUSE, STERISORB, and AMNIOARMOR. These are among 13 currently registered trademarks in the portfolio.
What is TISSUE TRANSPLANT TECHNOLOGY, LTD.'s trademark registration success rate?
TISSUE TRANSPLANT TECHNOLOGY, LTD. has a 62% trademark registration rate, with 13 out of 21 resolved applications resulting in successful registration. Currently, 0 applications are pending review.